chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Dyspnoea, Feeling abnormal, Inflammation, Musculoskeletal chest pain
Clinical narrative: pain in rib cage; Uncomfortable; something burning; Hard to breath; Inflammation; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Uncomfortable), BURNING SENSATION (something burning), DYSPNOEA (Hard to breath), INFLAMMATION (Inflammation) and MUSCULOSKELETAL CHEST PAIN (pain in rib cage) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included Hepatitis C. Concurrent medical conditions included Psoriasis (psoriasis stage 4), Thyroid disorder and Hypertension.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Uncomfortable), BURNING SENSATION (something burning), DYSPNOEA (Hard to breath), INFLAMMATION (Inflammation) and MUSCULOSKELETAL CHEST PAIN (pain in rib cage). At the time of the report, FEELING ABNORMAL (Uncomfortable), BURNING SENSATION (something burning), DYSPNOEA (Hard to breath), INFLAMMATION (Inflammation) and MUSCULOSKELETAL CHEST PAIN (pain in rib cage) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter No treatment information was provided
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot
Clinical narrative: Facial redness; Heat or warmness on her face; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Facial redness) and FEELING HOT (Heat or warmness on her face) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced ERYTHEMA (Facial redness) and FEELING HOT (Heat or warmness on her face). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Facial redness) and FEELING HOT (Heat or warmness on her face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: a bit of shortness of breath; A spontaneous report was received from consumer, concerning herself, a 71 -year-old  female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced bit of shortness of breath.  The patient's medical history was reported as known. Concomitants reported included Metoprolol, Tamsulosin, Gabapentin, metformin, fenofibrate, losartan were known.  On 8-Feb-2021, the patient received their first two of two planned doses of mRNA-1273 (Lot number: 024M20A), in the arm of COVID-19 infection.  On 8-FEB-2021, she experienced bit of shortness of breath.   Action taken with mRNA-1273 in response to the events was not reported.  The event, shortness of breath, was not reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Fatigue; chills; Fever; Muscle and body aches like carrying a heavy ball and chain; This spontaneous case was reported by a nurse and describes the occurrence of CHILLS (chills), PYREXIA (Fever), MYALGIA (Muscle and body aches like carrying a heavy ball and chain) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (Fever) and MYALGIA (Muscle and body aches like carrying a heavy ball and chain). On 08-Mar-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, CHILLS (chills), PYREXIA (Fever) and MYALGIA (Muscle and body aches like carrying a heavy ball and chain) had resolved and FATIGUE (Fatigue) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered CHILLS (chills), PYREXIA (Fever), MYALGIA (Muscle and body aches like carrying a heavy ball and chain) and FATIGUE (Fatigue) to be related.    No information regarding concomitant medication was provided.  No information regarding treatment was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Neuritis
Clinical narrative: After the first dose the patient´s nerves were much more irritating and they did not feel so good; acute pain and inflammation of their nerves, they are painful all over their body,; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (After the first dose the patient´s nerves were much more irritating and they did not feel so good) and NEURITIS (acute pain and inflammation of their nerves, they are painful all over their body,) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease, Thyroiditis and Neuropathy.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NEURALGIA (After the first dose the patient´s nerves were much more irritating and they did not feel so good) and NEURITIS (acute pain and inflammation of their nerves, they are painful all over their body,). At the time of the report, NEURALGIA (After the first dose the patient´s nerves were much more irritating and they did not feel so good) and NEURITIS (acute pain and inflammation of their nerves, they are painful all over their body,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment details were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-055521 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-055521:2nd dose
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Dizziness, Fatigue, Headache
Clinical narrative: 47 Days between 1st and 2nd dose; Feeling dizzy; Nauseous; Feeling wore out; Fatigue; Headaches; Tenderness at injection site; Diarrhea; Nausea; Fever started about 5pm the day after vaccination, lasted throughout the night, temperature never; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Tenderness at injection site), DIARRHEA (Diarrhea), NAUSEA (Nausea), PYREXIA (Fever started about 5pm the day after vaccination, lasted throughout the night, temperature never) and FATIGUE (Feeling wore out) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. #032L20A and #013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, RABEPRAZOLE SODIUM (ACIPHEX), PRAVASTATIN and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced INJECTION SITE PAIN (Tenderness at injection site), DIARRHEA (Diarrhea), NAUSEA (Nausea) and PYREXIA (Fever started about 5pm the day after vaccination, lasted throughout the night, temperature never). On 18-Mar-2021, the patient experienced FATIGUE (Feeling wore out), FATIGUE (Fatigue) and HEADACHE (Headaches). On 24-Mar-2021, the patient experienced DIZZINESS (Feeling dizzy) and NAUSEA (Nauseous). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (47 Days between 1st and 2nd dose). On 18-Mar-2021, PYREXIA (Fever started about 5pm the day after vaccination, lasted throughout the night, temperature never) had resolved. At the time of the report, INJECTION SITE PAIN (Tenderness at injection site), DIARRHEA (Diarrhea), NAUSEA (Nausea), FATIGUE (Feeling wore out), FATIGUE (Fatigue), HEADACHE (Headaches), DIZZINESS (Feeling dizzy) and NAUSEA (Nauseous) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (47 Days between 1st and 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information were reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Injection site pain, Nausea, Pyrexia
Clinical narrative: 47 Days between 1st and 2nd dose; Feeling dizzy; Nauseous; Feeling wore out; Fatigue; Headaches; Tenderness at injection site; Diarrhea; Nausea; Fever started about 5pm the day after vaccination, lasted throughout the night, temperature never; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Tenderness at injection site), DIARRHEA (Diarrhea), NAUSEA (Nausea), PYREXIA (Fever started about 5pm the day after vaccination, lasted throughout the night, temperature never) and FATIGUE (Feeling wore out) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. #032L20A and #013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, RABEPRAZOLE SODIUM (ACIPHEX), PRAVASTATIN and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced INJECTION SITE PAIN (Tenderness at injection site), DIARRHEA (Diarrhea), NAUSEA (Nausea) and PYREXIA (Fever started about 5pm the day after vaccination, lasted throughout the night, temperature never). On 18-Mar-2021, the patient experienced FATIGUE (Feeling wore out), FATIGUE (Fatigue) and HEADACHE (Headaches). On 24-Mar-2021, the patient experienced DIZZINESS (Feeling dizzy) and NAUSEA (Nauseous). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (47 Days between 1st and 2nd dose). On 18-Mar-2021, PYREXIA (Fever started about 5pm the day after vaccination, lasted throughout the night, temperature never) had resolved. At the time of the report, INJECTION SITE PAIN (Tenderness at injection site), DIARRHEA (Diarrhea), NAUSEA (Nausea), FATIGUE (Feeling wore out), FATIGUE (Fatigue), HEADACHE (Headaches), DIZZINESS (Feeling dizzy) and NAUSEA (Nauseous) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (47 Days between 1st and 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information were reported.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Pain in extremity
Clinical narrative: Fingers numb; Left arm hurts; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Fingers numb), PAIN IN EXTREMITY (Left arm hurts) and HEADACHE (Headache) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03821A) for COVID-19 vaccination.     No particular concomitant medications were reported.  Concurrent medical conditions included Blood pressure high and Gout.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced HYPOAESTHESIA (Fingers numb), PAIN IN EXTREMITY (Left arm hurts) and HEADACHE (Headache). At the time of the report, HYPOAESTHESIA (Fingers numb), PAIN IN EXTREMITY (Left arm hurts) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment taken by patient 65 years old male patient reported that he received 1st dose of Moderna vaccine on his left arm on 23Mar2021 and no symptom after administration. Since today morning 24Mar2021, his fingers become numb, left arm hurts and headache and still ongoing. no treatment taken. He is taking blood pressure and gout medicine as concomitant.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Rash, Rash pruritic, Swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (very itchy), SWELLING, VACCINATION SITE WARMTH, FEELING ABNORMAL, and DIZZINESS in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Stroke. Concomitant products included ATORVASTATIN, ASPIRIN, VITAMINS, and CLARITIN for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced RASH PRURITIC (very itchy), SWELLING, VACCINATION SITE WARMTH, FEELING ABNORMAL, DIZZINESS, and VACCINATION SITE RASH. On an unknown date, the patient experienced RASH. The patient was treated with HYDROCORTISONE for Rash, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (very itchy), SWELLING, VACCINATION SITE WARMTH, FEELING ABNORMAL, DIZZINESS, RASH and VACCINATION SITE RASH outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (very itchy), SWELLING, VACCINATION SITE WARMTH, FEELING ABNORMAL, and DIZZINESS in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Stroke. Concomitant products included ATORVASTATIN, ASPIRIN, VITAMINS, and CLARITIN for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced RASH PRURITIC (very itchy), SWELLING, VACCINATION SITE WARMTH, FEELING ABNORMAL, DIZZINESS, and VACCINATION SITE RASH. On an unknown date, the patient experienced RASH. The patient was treated with HYDROCORTISONE for Rash, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (very itchy), SWELLING, VACCINATION SITE WARMTH, FEELING ABNORMAL, DIZZINESS, RASH and VACCINATION SITE RASH outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Myalgia, Nasopharyngitis, Pain in extremity, Pyrexia
Clinical narrative: Cold; Arm feels like it is sore; Body is achy; Took my temperature and it was 101 degrees F; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold), PAIN IN EXTREMITY (Arm feels like it is sore), MYALGIA (Body is achy) and PYREXIA (Took my temperature and it was 101 degrees F) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced NASOPHARYNGITIS (Cold), PAIN IN EXTREMITY (Arm feels like it is sore), MYALGIA (Body is achy) and PYREXIA (Took my temperature and it was 101 degrees F). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (Cold), PAIN IN EXTREMITY (Arm feels like it is sore), MYALGIA (Body is achy) and PYREXIA (Took my temperature and it was 101 degrees F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 f (High) 101 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Injection site pain; dizziness; swollen lymph nodes; joint pain; headache; fever; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site pain), DIZZINESS (dizziness), LYMPHADENOPATHY (swollen lymph nodes), ARTHRALGIA (joint pain) and HEADACHE (headache) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain), DIZZINESS (dizziness), LYMPHADENOPATHY (swollen lymph nodes), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE PAIN (Injection site pain), DIZZINESS (dizziness), LYMPHADENOPATHY (swollen lymph nodes), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. /unknown.  Concomitant product use was not provided/unknown by the reporter.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain; dizziness; swollen lymph nodes; joint pain; headache; fever; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site pain), DIZZINESS (dizziness), LYMPHADENOPATHY (swollen lymph nodes), ARTHRALGIA (joint pain) and HEADACHE (headache) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain), DIZZINESS (dizziness), LYMPHADENOPATHY (swollen lymph nodes), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE PAIN (Injection site pain), DIZZINESS (dizziness), LYMPHADENOPATHY (swollen lymph nodes), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. /unknown.  Concomitant product use was not provided/unknown by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for Covid-19; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (tested positive for Covid-19) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20Q) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced COVID-19 (tested positive for Covid-19). At the time of the report, COVID-19 (tested positive for Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt). At the time of the report, PAIN IN EXTREMITY (arm hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Hot flush, Influenza like illness
Clinical narrative: Flu like symptom; Flashes; This spontaneous case was reported and describes the occurrence of INFLUENZA LIKE ILLNESS and HOT FLUSH in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included LYRICA and BACTRIM for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced HOT FLUSH. On 23-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS. At the time of the report, INFLUENZA LIKE ILLNESS and HOT FLUSH outcome was unknown. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact.
Sex: F
Vaccine: COVID19
Symptoms: Breast mass, Vaccination site nodule, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Painful nodules in arm and breast after 1st dose; Painful nodules in arm and breast after 1st dose; Arm warm after 1st dose; Arm swollen after 1st dose; Arm hurts after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of BREAST MASS (Painful nodules in arm and breast after 1st dose), VACCINATION SITE NODULE (Painful nodules in arm and breast after 1st dose), VACCINATION SITE WARMTH (Arm warm after 1st dose), VACCINATION SITE SWELLING (Arm swollen after 1st dose) and VACCINATION SITE PAIN (Arm hurts after 1st dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012a21a) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BREAST MASS (Painful nodules in arm and breast after 1st dose), VACCINATION SITE NODULE (Painful nodules in arm and breast after 1st dose), VACCINATION SITE WARMTH (Arm warm after 1st dose), VACCINATION SITE SWELLING (Arm swollen after 1st dose) and VACCINATION SITE PAIN (Arm hurts after 1st dose). At the time of the report, BREAST MASS (Painful nodules in arm and breast after 1st dose), VACCINATION SITE NODULE (Painful nodules in arm and breast after 1st dose), VACCINATION SITE WARMTH (Arm warm after 1st dose), VACCINATION SITE SWELLING (Arm swollen after 1st dose) and VACCINATION SITE PAIN (Arm hurts after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications were reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Injection site erythema, Injection site warmth, Pruritus
Clinical narrative: headache; flu-like symptoms; injection site was very red; rash; itchy; very hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), INJECTION SITE ERYTHEMA (injection site was very red), RASH (rash) and PRURITUS (itchy) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, AMLODIPINE, LISINOPRIL, TAMSULOSIN, LEVOTHYROXINE, FINASTERIDE, ATORVASTATIN and DOXYCYCLINE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), INJECTION SITE ERYTHEMA (injection site was very red), RASH (rash), PRURITUS (itchy) and INJECTION SITE WARMTH (very hot to the touch). At the time of the report, HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), INJECTION SITE ERYTHEMA (injection site was very red), RASH (rash), PRURITUS (itchy) and INJECTION SITE WARMTH (very hot to the touch) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    This case was linked to MOD-2021-056440 (Patient Link).
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: headache; flu-like symptoms; injection site was very red; rash; itchy; very hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), INJECTION SITE ERYTHEMA (injection site was very red), RASH (rash) and PRURITUS (itchy) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, AMLODIPINE, LISINOPRIL, TAMSULOSIN, LEVOTHYROXINE, FINASTERIDE, ATORVASTATIN and DOXYCYCLINE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), INJECTION SITE ERYTHEMA (injection site was very red), RASH (rash), PRURITUS (itchy) and INJECTION SITE WARMTH (very hot to the touch). At the time of the report, HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), INJECTION SITE ERYTHEMA (injection site was very red), RASH (rash), PRURITUS (itchy) and INJECTION SITE WARMTH (very hot to the touch) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    This case was linked to MOD-2021-056440 (Patient Link).
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A2119) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tiredness). At the time of the report, FATIGUE (Tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were provided. No concomitant medication were provided. Patient called in for the help in scheduling his second shot on 06th Apr 2021.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fatigue, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (lower back pain), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and FATIGUE (really fatigue) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 046A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 25-Mar-2021, the patient experienced BACK PAIN (lower back pain), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and FATIGUE (really fatigue). At the time of the report, BACK PAIN (lower back pain), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and FATIGUE (really fatigue) outcome was unknown.            Medications: high blood pressure - cholesterol - prostate medicine, "sisu" for facial convulsions
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: Missing second dose appointment; Got COVID after first dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got COVID after first dose) and PRODUCT DOSE OMISSION ISSUE (Missing second dose appointment) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced COVID-19 (Got COVID after first dose). On 25-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missing second dose appointment). On 25-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Missing second dose appointment) had resolved. At the time of the report, COVID-19 (Got COVID after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Caller reported, that his brother, received his first dose of Moderna Vaccine on 25-Feb-2021 and 2 weeks later contracted COVID. Brother's wife didn't get the vaccine and also tested positive for COVID at the same time her husband did. He had the virus for ten days now, doctors say that he was still recovering from it,  but COVID was almost over. Brother's second dose was scheduled today but he won't be able to get it.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: chills; fever; body ache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever) and MYALGIA (body ache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016821A) for COVID-19 vaccination.     Concurrent medical conditions included Ehlers-Danlos syndrome and Mast cell activation syndrome.    On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (fever) and MYALGIA (body ache). At the time of the report, CHILLS (chills), PYREXIA (fever) and MYALGIA (body ache) outcome was unknown.            Concomitant medications include medications for connective tissue disorder (Ehlers-Danlos syndrome) and Mast Cell Activation Syndrome.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cognitive disorder, Constipation, Feeling abnormal, Memory impairment
Clinical narrative: constipation; patient seems to be in a dense fog; patient does not remember speaking to the caller on two occasions during the morning which is; caller concerned that the vaccine has affected the patient's cognition; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (patient seems to be in a dense fog), MEMORY IMPAIRMENT (patient does not remember speaking to the caller on two occasions during the morning which is), COGNITIVE DISORDER (caller concerned that the vaccine has affected the patient's cognition) and CONSTIPATION (constipation) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included Surgery (geo blastoma with a mass the size of an avocado that was removed from his brain.) and Surgery (gamma knife surgery) in December 2020.    On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 25-Mar-2021, the patient experienced FEELING ABNORMAL (patient seems to be in a dense fog), MEMORY IMPAIRMENT (patient does not remember speaking to the caller on two occasions during the morning which is) and COGNITIVE DISORDER (caller concerned that the vaccine has affected the patient's cognition). On an unknown date, the patient experienced CONSTIPATION (constipation). At the time of the report, FEELING ABNORMAL (patient seems to be in a dense fog), MEMORY IMPAIRMENT (patient does not remember speaking to the caller on two occasions during the morning which is), COGNITIVE DISORDER (caller concerned that the vaccine has affected the patient's cognition) and CONSTIPATION (constipation) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-062435, US-MODERNATX, INC.-MOD-2021-057891 (Linked Report).; Sender's Comments:  MOD21-062435:MOD-2021-057891 - 1st dose of vaccine. US-MODERNATX, INC.-MOD-2021-057891:MOD-2021-057927 - 2nd dose of vaccine.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Myalgia, Pain in extremity, Swelling, Vaccination site pain
Clinical narrative: vaccination site on their arm is hurting; vaccination site on their arm is itching; vaccination site on their arm is burning; vaccination site on their arm is burning; it's sore; it really hurts; has about the size of their fist; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (vaccination site on their arm is hurting), VACCINATION SITE PRURITUS (vaccination site on their arm is itching), VACCINATION SITE PAIN (vaccination site on their arm is burning), ERYTHEMA (vaccination site on their arm is burning) and MYALGIA (it's sore) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE PAIN (vaccination site on their arm is hurting), VACCINATION SITE PRURITUS (vaccination site on their arm is itching), VACCINATION SITE PAIN (vaccination site on their arm is burning), ERYTHEMA (vaccination site on their arm is burning), MYALGIA (it's sore), PAIN IN EXTREMITY (it really hurts) and SWELLING (has about the size of their fist). At the time of the report, VACCINATION SITE PAIN (vaccination site on their arm is hurting), VACCINATION SITE PRURITUS (vaccination site on their arm is itching), VACCINATION SITE PAIN (vaccination site on their arm is burning), ERYTHEMA (vaccination site on their arm is burning), MYALGIA (it's sore), PAIN IN EXTREMITY (it really hurts) and SWELLING (has about the size of their fist) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient don't have lymph nodes on the left arm
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: vaccination site on their arm is hurting; vaccination site on their arm is itching; vaccination site on their arm is burning; vaccination site on their arm is burning; it's sore; it really hurts; has about the size of their fist; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (vaccination site on their arm is hurting), VACCINATION SITE PRURITUS (vaccination site on their arm is itching), VACCINATION SITE PAIN (vaccination site on their arm is burning), ERYTHEMA (vaccination site on their arm is burning) and MYALGIA (it's sore) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE PAIN (vaccination site on their arm is hurting), VACCINATION SITE PRURITUS (vaccination site on their arm is itching), VACCINATION SITE PAIN (vaccination site on their arm is burning), ERYTHEMA (vaccination site on their arm is burning), MYALGIA (it's sore), PAIN IN EXTREMITY (it really hurts) and SWELLING (has about the size of their fist). At the time of the report, VACCINATION SITE PAIN (vaccination site on their arm is hurting), VACCINATION SITE PRURITUS (vaccination site on their arm is itching), VACCINATION SITE PAIN (vaccination site on their arm is burning), ERYTHEMA (vaccination site on their arm is burning), MYALGIA (it's sore), PAIN IN EXTREMITY (it really hurts) and SWELLING (has about the size of their fist) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient don't have lymph nodes on the left arm
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced PRURITUS (itching). At the time of the report, PRURITUS (itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.   Reporter did not allow further contact
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Pruritus, Vaccination site pain
Clinical narrative: Arm didn't feel right; Spot was itching; Soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness of arm), LIMB DISCOMFORT (Arm didn't feel right) and PRURITUS (Spot was itching) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0BL20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness of arm). On an unknown date, the patient experienced LIMB DISCOMFORT (Arm didn't feel right) and PRURITUS (Spot was itching). At the time of the report, VACCINATION SITE PAIN (Soreness of arm), LIMB DISCOMFORT (Arm didn't feel right) and PRURITUS (Spot was itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Event outcome and additional events updated
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Vaccination site reaction, Vaccination site warmth
Clinical narrative: swelling of arm; itchy; red patch around vaccination site; warm to touch; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling of arm), PRURITUS (itchy), VACCINATION SITE REACTION (red patch around vaccination site) and VACCINATION SITE WARMTH (warm to touch) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling of arm), PRURITUS (itchy), VACCINATION SITE REACTION (red patch around vaccination site) and VACCINATION SITE WARMTH (warm to touch). At the time of the report, PERIPHERAL SWELLING (swelling of arm), PRURITUS (itchy), VACCINATION SITE REACTION (red patch around vaccination site) and VACCINATION SITE WARMTH (warm to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Nausea, Pain, Pyrexia
Clinical narrative: stomach upset; bodyaches; fever; nauseated; episodes of vomiting; tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach upset), PAIN (bodyaches), PYREXIA (fever), NAUSEA (nauseated) and VOMITING (episodes of vomiting) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach upset), PAIN (bodyaches), PYREXIA (fever), NAUSEA (nauseated), VOMITING (episodes of vomiting) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Mar-2021, ABDOMINAL DISCOMFORT (stomach upset), PAIN (bodyaches), PYREXIA (fever), NAUSEA (nauseated), VOMITING (episodes of vomiting) and FATIGUE (tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other relevant concomitant medication included Diabetes and Emphysema.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: stomach upset; bodyaches; fever; nauseated; episodes of vomiting; tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach upset), PAIN (bodyaches), PYREXIA (fever), NAUSEA (nauseated) and VOMITING (episodes of vomiting) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach upset), PAIN (bodyaches), PYREXIA (fever), NAUSEA (nauseated), VOMITING (episodes of vomiting) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Mar-2021, ABDOMINAL DISCOMFORT (stomach upset), PAIN (bodyaches), PYREXIA (fever), NAUSEA (nauseated), VOMITING (episodes of vomiting) and FATIGUE (tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other relevant concomitant medication included Diabetes and Emphysema.